Citation Impact
Citing Papers
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
2009 Standout
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
Relative resistance of HIV-1 founder viruses to control by interferon-alpha
2013
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
PQBP1 Is a Proximal Sensor of the cGAS-Dependent Innate Response to HIV-1
2015
Persistent immune activation in chronic HIV infection
2013
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Eradicating HIV-1 infection: seeking to clear a persistent pathogen
2014
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
2014
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
IL-15: targeting CD8+T cells for immunotherapy
2005
Breaking down the barrier: The effects of HIV-1 on the blood–brain barrier
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Sex Hormones Determine Immune Response
2018
Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
2016 Standout
Features of the dendritic cell lineage
2010 StandoutNobel
Elevated 17β-Estradiol Protects Females from Influenza A Virus Pathogenesis by Suppressing Inflammatory Responses
2011
HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications
2011
Sex differences in immune responses to infectious diseases
2015
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance
2010
Microglial cell origin and phenotypes in health and disease
2011 Standout
Activation of host pattern recognition receptors by viruses
2010
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
2012
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards
2012 StandoutNobel
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Increase in 2–Long Terminal Repeat Circles and Decrease in D-dimer After Raltegravir Intensification in Patients With Treated HIV Infection: A Randomized, Placebo-Controlled Trial
2013
Relationship between T Cell Activation and CD4 + T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy
2007
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Dissection of Regenerating T-Cell Responses against Tuberculosis in HIV-infected Adults Sensitized by Mycobacterium tuberculosis
2009
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
2011
Estrogen receptors regulate innate immune cells and signaling pathways
2015
Prevalence of protective antibody against measles in HIV‐infected children with immune recovery after highly active antiretroviral therapy
2006
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2020 Standout
The Xs and Y of immune responses to viral vaccines
2010
MX2 is an interferon-induced inhibitor of HIV-1 infection
2013 StandoutNatureNobel
Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy
2004
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection
2013 Nature
HIV-1 and interferons: who's interfering with whom?
2015
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
2011
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
2011
The impact of sex, gender and pregnancy on 2009 H1N1 disease
2010
Randomised, Placebo-Controlled, Phase I/IIa Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-? in HIV-1 Infected Subjects
2005 StandoutNobel
Host-directed therapies for bacterial and viral infections
2017
Considering how biological sex impacts immune responses and COVID-19 outcomes
2020
Sex differences in immune responses
2016 Standout
An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
2012
Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males
2012
The Hallmarks of Aging
2013 Standout
SeXX Matters in Infectious Disease Pathogenesis
2016
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
T Cells Detect Intracellular DNA but Fail to Induce Type I IFN Responses: Implications for Restriction of HIV Replication
2014
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
2016 StandoutNobel
Sexual Dimorphism in Innate Immunity
2017
Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques
2002
Production of amphiregulin and recovery from influenza is greater in males than females
2018
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA
2016
Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells
2010 StandoutNobel
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
2017
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma
2006
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Adipose-Derived Stem Cells for Regenerative Medicine
2007 Standout
Quantitative Proteomic Analysis of the Secretory Proteins from Rat Adipose Cells Using a 2D Liquid Chromatography−MS/MS Approach
2005
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
HIV Infection, Inflammation, Immunosenescence, and Aging
2010
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Immune activation and HIV persistence: implications for curative approaches to HIV infection
2013
Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral Therapy
2014
HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals
2010 ScienceNobel
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex
2016 StandoutNobel
Critical role of CD4 T cells in maintaining lymphoid tissue structure for immune cell homeostasis and reconstitution
2012
The Immune Response in Tuberculosis
2013 Standout
The Envelope Gene of Transmitted HIV-1 Resists a Late Interferon Gamma-Induced Block
2017
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
2015
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Towards an HIV cure: a global scientific strategy
2012
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
2010
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Characterization of the Alpha Interferon-Induced Postentry Block to HIV-1 Infection in Primary Human Macrophages and T Cells
2010
B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
2010
Plasmacytoid Dendritic Cells: Recent Progress and Open Questions
2011
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling
2011
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
2012
Host and Viral Determinants of Mx2 Antiretroviral Activity
2014
Microbial Translocation Across the GI Tract
2012
IL-15: targeting CD8+ T cells for immunotherapy
2005
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Ellen S. Chan being referenced
Evidence of Immune Reconstitution in Antiretroviral Drug-Experienced Patients with Advanced HIV Disease
2002
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy
2011
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
2009
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection
2002
Interleukin‐2 Increases CD4+Lymphocyte Numbers but Does Not Enhance Responses to Immunization: Results of A5046s
2003
Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
2010
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
2010
Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects
2006
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
2009
Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384
2009
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical Trial
2010